Table 2.
Effect of haloxyfop-p methyl ester on plasma biomarkers of hepatic function in rat.
| Treatment groups | Bilirubin (mg/dL) | ALP (U/L) | ALT (U/L) | AST (U/L) |
|---|---|---|---|---|
| 0 (Control) | 0.29 ± 0.01 | 262.8 ± 8.6 | 30.4 ± 3.1 | 61.2 ± 5.6 |
| 6.75 mg/kg bw HPME | 0.37 ± 0.01 (28%) * | 355.4 ± 9.1 (35%) * | 36.0 ± 2.6 (18%) * | 66.4 ± 4.1 (8%) * |
| 13.50 mg/kg bw HPME | 0.47 ± 0.02 (62%) * | 384.2 ± 6.6 (46%) * | 41.1 ± 2.3 (35%) * | 73.4 ± 5.1 (20%) * |
| 27.00 mg/kg bw HPME | 0.57 ± 0.01 (97%) * | 438.8 ± 7.4 (67%) * | 45.2 ± 3.6 (49%) * | 77.0 ± 2.7 (26%) * |
Values are the means ± SD for six replicates; * values significantly different from the control at p ˂ 0.05; values in parenthesis represent the percentage (%) increase compared to the control.